Join Our Newsletter

Clinical Trials .

List of currently ongoing clinical studies involving KetoCitra and/or the Ren-Nu program. This page is for informational purposes only. Please refer to the sponsoring institutions for detailed information about these studies and learn whether you may qualify to enroll.

Juntendo University, Tokyo, Japan

Intervention: 12 month ketogenic diet with KetoCitra compared to matched control group with no nutritional change and no KetoCitra.

Size: 50 participants in intervention arm

Trial leaders: Haruna Kawano, M.D. Ph.D and Shigeo Horie, MD
Department of Urology
Juntendo University, Graduate School of Medicine

Status: Ongoing, completed enrollment

Information

Cleveland Clinic, Cleveland Ohio

Title: Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney Disease (PKD-KETO)

Intervention: 3 month Ren-Nu.org nutritional program with KetoCitra.

Size: 20 participants

Trial leader: Richard Fatica, MD
Vice Chair of Nephrology and Hypertension, The Cleveland Clinic

Status: Ongoing, currently enrolling

Information

The Royal Melbourne Hospital, Melbourne, Australia

Title: An interventional assessment of the metabolic effects of a low-carbohydrate/ketogenic diet combined with ketone supplementation in adults with Autosomal Dominant Polysystic Kidney Disease (ADPKD).

Intervention: 12 weeks of KetoCitra with low-carbohydrate nutritional change.

Size: Up to 50 participants

Trial leader: Karen Dwyer MBBS; PhD; FRACP; FASLM
Director of Nephrology, The Royal Melbourne Hospital
Professor of Nephrology, University of Melbourne

Status: Ongoing, recruiting

Information

University of Southern California, Los Angeles

Title: Long COVID-19 Syndrome Lifestyle Intervention Study

Intervention: Dietary intervention with Ketocitra versus control arm (no intervention) in a 1:1 ratio

Trial leader: Núria M. Pastor-Soler, MD, PhD, FASN
Division of Nephrology, Larner College of Medicine, University of Vermont

Status: Completed, publication pending

Information